FDA Inspection 1276120 — Biosint S.P.A.
The FDA completed an inspection of Biosint S.P.A. on Jul 18, 2024 in Sermoneta. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Jul 18, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Sermoneta (Italy)
Additional Details
Mutual Recognition Agreement (MRA)